| Primary information |
|---|
| sequence ID | Seq_3025 |
| Peptide sequence | GPPPPGKPQ |
| CancerPDF_ID | CancerPDF_ID3864, CancerPDF_ID3865, CancerPDF_ID3881, CancerPDF_ID3882, CancerPDF_ID3903, CancerPDF_ID3904, CancerPDF_ID3941, |
| PMID | 22809520,22809520,22809520,22809520,22809520,22809520,22809520 |
| Protein Name | Basic PRP1 (Basic salivary proline-rich protein 1),Basic PRP1 (Basic salivary proline-rich protein 1),Basic PRP2 (Basic salivary proline-rich protein 2),Basic PRP2 (Basic salivary proline-rich protein 2),Basic PRP2 (Basic salivary proline-rich protein 2),Basic PRP2 (Basic salivary proline-rich protein 2),Basic PRP4 (Basic salivary proline-rich protein 4) |
| UniprotKB Entry Name | PRP1_HUMAN,PRP1_HUMAN,PRPC_HUMAN,PRPC_HUMAN,PRPC_HUMAN,PRPC_HUMAN,A0A0A0MT31_HUMAN |
| Fluid | Saliva,Saliva,Saliva,Saliva,Saliva,Saliva,Saliva |
| M/Z | NA,NA,NA,NA,NA,NA,NA |
| Charge | NA,NA,NA,NA,NA,NA,NA |
| Mass (in Da) | NA,NA,NA,NA,NA,NA,NA |
| fdr | 1482.89,1206.68,1206.68,1482.89,1206.68,1482.89,1206.68 |
| Profiling Technique | LC-MS and iTRAQ,LC-MS and iTRAQ,LC-MS and iTRAQ,LC-MS and iTRAQ,LC-MS and iTRAQ,LC-MS and iTRAQ,LC-MS and iTRAQ |
| Peptide Identification technique | MS/MS,MS/MS,MS/MS,MS/MS,MS/MS,MS/MS,MS/MS |
| Quantification Technique | "2,4,6-trinitrobenzenesulfonic acid assay","2,4,6-trinitrobenzenesulfonic acid assay","2,4,6-trinitrobenzenesulfonic acid assay","2,4,6-trinitrobenzenesulfonic acid assay","2,4,6-trinitrobenzenesulfonic acid assay","2,4,6-trinitrobenzenesulfonic acid assay","2,4,6-trinitrobenzenesulfonic acid assay" |
| Labelled/Label Free | Labelled,Labelled,Labelled,Labelled,Labelled,Labelled,Labelled |
| FDR | NA,NA,NA,NA,NA,NA,NA |
| CancerPDF_ID | CancerPDF_ID3864, CancerPDF_ID3865, CancerPDF_ID3881, CancerPDF_ID3882, CancerPDF_ID3903, CancerPDF_ID3904, CancerPDF_ID3941, |
| p-Value | NA,NA,NA,NA,NA,NA,NA |
| Software | MASCOT (v2.1.1),MASCOT (v2.1.1),MASCOT (v2.1.1),MASCOT (v2.1.1),MASCOT (v2.1.1),MASCOT (v2.1.1),MASCOT (v2.1.1) |
| Length | 9,9,9,9,9,9,9 |
| Cancer Type | Normal,Normal,Normal,Normal,Normal,Normal,Normal |
| Database | SwissProt Database (release date 010111),SwissProt Database (release date 010111),SwissProt Database (release date 010111),SwissProt Database (release date 010111),SwissProt Database (release date 010111),SwissProt Database (release date 010111),SwissProt Database (release date 010111) |
| Modification | iTRAQ8plex at N-term; iTRAQ8plex(K) at 7,iTRAQ8plex at N-term; iTRAQ8plex(K) at 7,iTRAQ8plex(K) at 9; Formyl at N-term;,iTRAQ8plex at N-term; iTRAQ8plex(K) at 7,NA,NA,FormylatN-term; iTRAQ8plex(K)at7 |
| Number of Patients | NA,NA,NA,NA,NA,NA,NA |
| Regulation | NA,NA,NA,NA,NA,NA,NA |
| Validation | NA,NA,NA,NA,NA,NA,NA |
| Sensitivity | NA,NA,NA,NA,NA,NA,NA |
| Specificity | NA,NA,NA,NA,NA,NA,NA |
| Accuracy | NA,NA,NA,NA,NA,NA,NA |
| Peptide Atlas | NA |
| IEDB | 505665
|